Skip to main navigation Skip to search Skip to main content

Erratum to Deletion of Rv2571c Confers Resistance to Arylamide Compounds in Mycobacterium tuberculosis (Antimicrobial Agents and Chemotherapy (2021) 65:5 (e02334-e02320) DOI: 10.1128/aac.02334-20)

  • Catherine D. Shelton
  • , Matthew B. McNeil
  • , Julie V. Early
  • , Thomas R. Ioerger
  • , Tanya Parish
  • Infectious Disease Research Institute
  • Seattle Children's Hospital
  • Texas A&M University

Research output: Contribution to journalComment/debate

Abstract

Volume 65, no. 5, e02334-20, 2021, https://doi.org/10.1128/aac.02334-20. The following statement should appear in the Acknowledgments section: “The compounds in this article were designed and synthesized at H3D (University of Cape Town). We thank Richard Gessner and Grant Boyle for synthesizing the compounds, as well as Kelly Chibale, Leslie Street, and Sandeep Ghorpade for helpful discussion.”

Original languageEnglish
JournalAntimicrobial Agents and Chemotherapy
Volume66
Issue number8
DOIs
Publication statusPublished - 25 Jul 2022
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Erratum to Deletion of Rv2571c Confers Resistance to Arylamide Compounds in Mycobacterium tuberculosis (Antimicrobial Agents and Chemotherapy (2021) 65:5 (e02334-e02320) DOI: 10.1128/aac.02334-20)'. Together they form a unique fingerprint.

Cite this